[Persisting extrapyramidal syndrome following neuroleptic therapy].
D000588:Amines / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D004298:Dopamine / Q000627:therapeutic use; D005116:Extrapyramidal Tracts; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D013118:Spinal Cord Diseases / Q000139:chemically induced*; D014149:Tranquilizing Agents / Q000009:adverse effects*
D000588:Amines; D014149:Tranquilizing Agents; D006220:Haloperidol; D004298:Dopamine
Syndrome extra-pyramidal durable après traitement neuroleptique.